Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Dexcom (NQ: DXCM )

396.67 USD -1.11 (-0.28%)
Official Closing Price Updated: 4:59 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Dexcom

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
DexCom to Present at William Blair Growth Stock Conference
From Business Wire News Releases
DexCom to Present at Canaccord Adams Diabetes & Obesity Conference
From Business Wire News Releases
DexCom Appoints Jonathan Lord, M.D. as Board Member
From Business Wire News Releases
DexCom to Present at 2008 Citi Investment Research Global Health Care Conference
From Business Wire News Releases
DexCom, Inc. Reports First Quarter 2008 Financial Results
From Business Wire News Releases
DexCom Schedules First Quarter 2008 Earnings Release and Conference Call for May 8, 2008
From Business Wire News Releases
DexCom To Present at the Cowen and Company 28th Annual Health Care Conference in Boston
From Business Wire News Releases
DexCom Inc. Reports 2007 Financial Results
From Business Wire News Releases
DexCom Schedules Fourth Quarter and Full Year 2007 Earnings Release and Conference Call for March 11, 2008
From Business Wire News Releases
DexCom(TM) Announces Joint Development Agreement with Animas Corporation
Partnership Will Focus on Developing a Continuous Glucose Monitoring System to Work with Animas(R) Insulin Pumps 
From Business Wire News Releases
Insulet Corporation and DexCom Announce Development Agreement
Insulet's OmniPod(R) Personal Diabetes Manager to Integrate DexCom Continuous Glucose Monitoring Technology 
From PR Newswire
DexCom To Present at 26th Annual JP Morgan Healthcare Conference in San Francisco
From Business Wire News Releases
DexCom(TM) Receives FDA Approval to Calibrate Its SEVEN(TM) Continuous Glucose Monitoring System Using Any FDA Cleared Blood Glucose Meter
Approval Allows Patients to Manually Enter Calibration Data Directly into the Seven(TM) 
From Business Wire News Releases
DexCom to Present at the 19th Annual Piper Jaffray Health Care Conference & the Lazard Capital Markets Fourth Annual Healthcare Conference
From Business Wire News Releases
DexCom Inc. Reports Third Quarter 2007 Financial Results
From Business Wire News Releases
DexCom Schedules 2007 Third Quarter Earnings Release and Conference Call for October 30, 2007 and Announces Conference Participation
From Business Wire News Releases
DexCom To Present at Think Equity Partners 5th Annual Growth Conference & UBS Global Life Sciences Conference
From Business Wire News Releases
DexCom Announces CFO Retirement, Appointment of Interim CFO and Executive Promotions
From Business Wire News Releases
DexCom Inc. Reports Second Quarter 2007 Financial Results
From Business Wire News Releases
DexCom to Present at Canaccord Adams' 27th Global Growth Conference in Boston
From Business Wire News Releases
DexCom Schedules 2007 Second Quarter Earnings Release and Conference Call for July 30, 2007
From Business Wire News Releases
DexCom(TM) Appoints Terrance H. Gregg as CEO
Terrance H. Gregg, Former President and Chief Operating Officer of MiniMed, to Succeed Andy Rasdal as President and Chief Executive Officer 
From Business Wire News Releases
UPDATE: DexCom(TM) Updates Webcast & Dial-in Information for Conference Call to Discuss Approval and Launch of Its Recently Approved 7-Day STS(R) Continuous Glucose Monitoring System
From Business Wire News Releases
DexCom(TM) Schedules Conference Call to Discuss Approval and Launch of Its Recently Approved 7-Day STS(R) Continuous Glucose Monitoring System
From Business Wire News Releases
(OTC: TFZP) Introduces Automated Hydration Equipment for High Volume Perishable Shipping
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit. 
From Marketwired News Releases
DexCom(TM) Receives FDA Approval for Its 7-Day STS(R) Continuous Glucose Monitoring System
SEVEN(TM) is the First Continuous Glucose Monitoring System to Be Approved for up to Seven Days of Continual Use 
From Business Wire News Releases
DexCom Inc. Reports First Quarter 2007 Financial Results
From Business Wire News Releases
DexCom Schedules 2007 First Quarter Earnings Release and Conference Call for May 9, 2007 and Announces Conference Participation
From Business Wire News Releases
DexCom Prices an Additional $20 Million of Convertible Senior Notes and Purchases Issuer Call Spread Options
From Business Wire News Releases
DexCom Prices $40 Million of Convertible Senior Notes
From Business Wire News Releases
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.